Use of Thiazolidinediones and Risk of Heart Failure in People With Type 2 Diabetes: A Retrospective Cohort Study
- 1 March 2004
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 27 (3) , 850-851
- https://doi.org/10.2337/diacare.27.3.850-a
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Thiazolidinedione Use, Fluid Retention, and Congestive Heart FailureDiabetes Care, 2004
- Use of Thiazolidinediones and Risk of Heart Failure in People With Type 2 DiabetesDiabetes Care, 2003
- Evaluating Medication Effects Outside of Clinical Trials: New-User DesignsAmerican Journal of Epidemiology, 2003
- Metformin and Thiazolidinedione Use in Medicare Patients With Heart FailureJAMA, 2003
- Fluid retention after initiation of thiazolidinedione therapy in diabetic patients with established chronic heart failureJournal of the American College of Cardiology, 2003
- Oral Antihyperglycemic Therapy for Type 2 DiabetesJAMA, 2002
- Making Medicines Safer — The Need for an Independent Drug Safety BoardNew England Journal of Medicine, 1998
- Evaluating Drugs after Their Approval for Clinical UseNew England Journal of Medicine, 1993
- Introducing MEDWatchJAMA, 1993
- Introducing MEDWatch. A new approach to reporting medication and device adverse effects and product problemsJAMA, 1993